LEVONORGESTREL - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for levonorgestrel and what is the scope of patent protection?
Levonorgestrel
is the generic ingredient in fourteen branded drugs marketed by Population Council, Wyeth Pharms Inc, Bayer Hlthcare, Medicines360, Aurobindo Pharma, Lupin Ltd, Novast Labs, Alvogen, Fdn Consumer, Glenmark Pharms Ltd, L Perrigo Co, Laboratoire Hra, Lotus Pharm Co Ltd, Mylan Labs Ltd, Naari Pte Ltd, Novel Labs Inc, Perrigo R And D, Watson Labs, Xiromed, and Sun Pharm, and is included in thirty NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Levonorgestrel has one hundred and ten patent family members in thirty-five countries.
There are twenty drug master file entries for levonorgestrel. Thirty-five suppliers are listed for this compound.
Summary for LEVONORGESTREL
International Patents: | 110 |
US Patents: | 6 |
Tradenames: | 14 |
Applicants: | 20 |
NDAs: | 30 |
Drug Master File Entries: | 20 |
Finished Product Suppliers / Packagers: | 35 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 250 |
Patent Applications: | 5,759 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for LEVONORGESTREL |
What excipients (inactive ingredients) are in LEVONORGESTREL? | LEVONORGESTREL excipients list |
DailyMed Link: | LEVONORGESTREL at DailyMed |
Recent Clinical Trials for LEVONORGESTREL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexion Pharmaceuticals, Inc. | Phase 1 |
Washington University School of Medicine | Phase 2 |
Novo Nordisk A/S | Phase 2 |
Pharmacology for LEVONORGESTREL
Drug Class | Progestin Progestin-containing Intrauterine Device Progestin-containing Intrauterine System |
Physiological Effect | Inhibit Ovum Fertilization |
Medical Subject Heading (MeSH) Categories for LEVONORGESTREL
US Patents and Regulatory Information for LEVONORGESTREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharms Ltd | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 207044-001 | Mar 25, 2016 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Medicines360 | LILETTA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Bayer Hlthcare | SKYLA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 203159-001 | Jan 9, 2013 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Watson Labs | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 078666-001 | Jun 24, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Naari Pte Ltd | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 202380-001 | May 29, 2015 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fdn Consumer | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 200670-001 | Jul 12, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEVONORGESTREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | SKYLA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 203159-001 | Jan 9, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | MIRENA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 021225-001 | Dec 6, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | KYLEENA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 208224-001 | Sep 16, 2016 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEVONORGESTREL
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 339210 | ⤷ Sign Up | |
Poland | 2352470 | ⤷ Sign Up | |
Spain | 2401551 | ⤷ Sign Up | |
Canada | 2736020 | DISPOSITIF D'INTRODUCTION (AN INSERTER) | ⤷ Sign Up |
Brazil | PI0612196 | sistema intra-uterino ultra-sonicamente detectável, e método para melhorar a visualização de um sistema intra-uterino | ⤷ Sign Up |
Denmark | 2352470 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LEVONORGESTREL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | C 2015 029 | Romania | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129 |
1453521 | 300814 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1453521 | 39/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1453521 | 122015000093 | Germany | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
1453521 | 15C0050 | France | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
1453521 | 93156 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.